Zobrazeno 1 - 10
of 25
pro vyhledávání: '"David Fleet"'
Autor:
Adam Cadotte, David W Cadotte, Micha Livne, Julien Cohen-Adad, David Fleet, David Mikulis, Michael G Fehlings
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0139323 (2015)
Spinal cord segmentation is a developing area of research intended to aid the processing and interpretation of advanced magnetic resonance imaging (MRI). For example, high resolution three-dimensional volumes can be segmented to provide a measurement
Externí odkaz:
https://doaj.org/article/e6cf0bddfe2349d198f6362f34577692
Autor:
Ali Punjani, David Fleet
Publikováno v:
Microscopy and Microanalysis. 28:1218-1218
Publikováno v:
Protocol Exchange.
Autor:
David Fleet, Patricia J. Schlicht, Jaspreet S. Brar, Christopher R. Bowie, Ripu D. Jindal, K. N. Roy Chengappa
Publikováno v:
The Journal of Clinical Psychiatry. 74:1076-1083
Objective: Cognitive impairments contribute significantly to inadequate functional recovery following illness episodes in bipolar disorder, yet data on treatment interventions are sparse. We assessed the cognitive effects of a standardized extract of
Autor:
Belén Gómez-Carrillo, Teresa Leon, David Fleet, María V. Andrés, Pilar Redondo, Klaus C. Steinwachs, Miguel Medina, Hermann Josef Gertz, Teodoro Del Ser, Joan A. Vericat
Publikováno v:
Journal of Alzheimer's Disease. 33:205-215
This pilot, double-blind, placebo-controlled, randomized, escalating dose trial explored the safety and efficacy of tideglusib, an inhibitor of glycogen synthase kinase-3, in Alzheimer's disease (AD) patients. Thirty mild-moderate AD patients on chol
Autor:
Christopher R. Bowie, Sherry L. Murphy, Scott R. Turkin, Susan DeSanti, Patricia J. Schlicht, Michelle L. Hetrick, Robert M. Bilder, David Fleet, K. N. Roy Chengappa, Jaspreet S. Brar
Publikováno v:
Schizophrenia Research. 142:145-152
Background Targeting glutamatergic dysfunction provides an exciting opportunity to improve cognitive impairment in schizophrenia. One treatment approach has targeted inadequate antioxidant defenses at glutamatergic synapses. Animal and human data sug
Autor:
Jochen Zisowsky, Jasper Dingemanse, Matthias Hoch, Anthony Priestley, David Fleet, Petra Hoever
Publikováno v:
Pharmacology. 89:53-57
Background/Aims: The aim of this single-center, open-label study was to assess the absolute bioavailability of an oral (tablet) versus intravenous formulation of almorexant in healthy subjects. Methods: A pilot phase in 3 healthy male subjects, which
Publikováno v:
Alzheimer's Research & Therapy
An important factor in the universal failure in phase III trials in mild to moderate Alzheimer’s disease in the past decade is the lack of phase II clinical data prior to entering phase III, with common reliance on biomarker results alone. Conducti
The seven-volume set comprising LNCS volumes 8689-8695 constitutes the refereed proceedings of the 13th European Conference on Computer Vision, ECCV 2014, held in Zurich, Switzerland, in September 2014.The 363 revised papers presented were carefully
The seven-volume set comprising LNCS volumes 8689-8695 constitutes the refereed proceedings of the 13th European Conference on Computer Vision, ECCV 2014, held in Zurich, Switzerland, in September 2014. The 363 revised papers presented were carefully